Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Felton

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Scientific Reports|July 27, 2025
Correction: Development and validation of the airway surgery enclosure for high-risk aerosol-generating airway procedures: a bench and clinical studyNeil K Chadha, Jason Powell, Katharina Leitmeyer, et al.
Scientific Reports|July 2, 2025
Development and validation of the airway surgery enclosure for high-risk aerosol-generating airway procedures: a bench and clinical studyNeil K Chadha, Jason Powell, Katharina Leitmeyer, et al.
The American Journal of Tropical Medicine and Hygiene|November 12, 2005
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in KenyaMonique K Wasunna, Juma R Rashid, Jane Mbui, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Scientific Reports|July 27, 2025
Correction: Development and validation of the airway surgery enclosure for high-risk aerosol-generating airway procedures: a bench and clinical studyNeil K Chadha, Jason Powell, Katharina Leitmeyer, et al.
Scientific Reports|July 2, 2025
Development and validation of the airway surgery enclosure for high-risk aerosol-generating airway procedures: a bench and clinical studyNeil K Chadha, Jason Powell, Katharina Leitmeyer, et al.
The American Journal of Tropical Medicine and Hygiene|November 12, 2005
A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in KenyaMonique K Wasunna, Juma R Rashid, Jane Mbui, et al.
Pageof 2